Literature DB >> 17011264

The significance of serum hepatocyte growth factor levels in planning follow-up of postoperative jaundice-free patients with biliary atresia.

Keiichi Uchida1, Mikihiro Inoue, Kohei Otake, Shigeyuki Yoshiyama, Yuji Toiyama, Junichiro Hiro, Toshimitsu Araki, Chikao Miki, Masato Kusunoki.   

Abstract

PURPOSE: The aim of this study was to clarify the significance of serum hepatocyte growth factor (HGF), interleukin (IL)-6, and IL-1 receptor antagonist (ra) levels in the evaluation of disease status in jaundice-free survivors with biliary atresia after Kasai operation. PATIENTS AND METHODS: Serum concentrations of HGF, IL-6, and IL-ra were measured in 31 long-term jaundice-free patients with biliary atresia after Kasai operation and 29 controls. Patients were divided into 4 groups: group A (n = 8), normal liver function; group B (n = 9), mild liver dysfunction without portal hypertension; group C (n = 9), moderate liver dysfunction with controllable portal hypertension; and group D (n = 5), receiving liver transplantation.
RESULTS: Serum IL-6 levels were significantly higher in patients than in controls. There was no difference in serum IL-6 levels among groups B, C, and D. Serum IL-1ra levels were elevated according to liver dysfunction. Serum HGF levels in group D were significantly higher than in controls and the other groups. Serum hyaluronic acid levels were positively correlated with serum levels of IL-1ra and HGF.
CONCLUSIONS: Elevation of serum IL-1ra and HGF levels correlated with the progression of liver fibrosis and dysfunction. In particular, serum HGF levels could be used as a predictor for requiring liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17011264     DOI: 10.1016/j.jpedsurg.2006.05.058

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  3 in total

1.  Hepatic expression of HGF/C-met and native liver survival in biliary atresia.

Authors:  Panicha Tangtrongchitr; Sopee Poomsawat; Voranush Chongsrisawat; Sittisak Honsawek; Yong Poovorawan; Yuda Chongpison; Paisarn Vejchapipat
Journal:  Pediatr Surg Int       Date:  2020-03-21       Impact factor: 1.827

2.  Systemic cytokine profiles in biliary atresia.

Authors:  Wanvisa Udomsinprasert; Tachatra Ungsudechachai; Paisarn Vejchapipat; Yong Poovorawan; Sittisak Honsawek
Journal:  PLoS One       Date:  2022-04-22       Impact factor: 3.240

3.  Bone health in a nonjaundiced population of children with biliary atresia.

Authors:  Rachel A Kramer; Babette S Zemel; Jessica L Arvay-Nezu; Virginia A Stallings; Mary B Leonard; Barbara A Haber
Journal:  Gastroenterol Res Pract       Date:  2009-07-05       Impact factor: 2.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.